PACS Group, Inc. (PACS), a post-acute healthcare company, has announced the pricing of its expanded public offering of 16.55 million shares at $36.25 per share. This offering is composed of 2.78 million shares sold directly by the company and an increased number of 13.77 million shares sold by certain shareholders, up from the initially planned 11.11 million shares. PACS is set to raise gross proceeds of $101 million through this offering. Citigroup, J.P. Morgan, and Truist Securities are serving as the lead book-running managers for the offering, which is anticipated to close on September 9.